BackExact Sciences Overview

Exact Sciences Other Assets

Latest other assets for EXAS: $310M.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$312.10M
83.89% YoYΔ $142.37M vs prior year quarter

Peer trimmed avg / median

Loading

Exact Sciences Other Assets History

Loading

Exact Sciences vs. peers: Other Assets Comparison

Loading

Exact Sciences Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Exact Sciences (EXAS) FAQ

Exact Sciences's other assets stands at $310M as of December 2025. That compares with $170M in the prior-year period — up 83.9% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Exact Sciences reported $310M in other assets versus $170M a year earlier — a 83.9% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $170M in the prior-year period — up 83.9% year over year. Sustained growth in other assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Exact Sciences's other assets evolved across reporting periods, while the comparison chart places EXAS next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, other assets is commonly used to spot outliers. Exact Sciences's reading of $310M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.